Abstract
Purpose
To report on our institutional cohort of patients and review the literature of medulloblastoma patients who developed skull/subdural-based lesions following treatment.
Methods
Following institutional review board (IRB) approval, we retrospectively reviewed the medical records of four children with a history of treated medulloblastoma who developed non-specific skull-based/subdural lesions incidentally found on surveillance imaging.
Results
Biopsies of the lesions proved the pathology to be low grade and included inflammatory myofibroblastic tumor, cortical fibrous defect consistent with fibroma, fibrous tissue, and fibrous dysplasia. The finding of calvarial or subdural fibrous lesions in children following therapy for medulloblastoma was noted in four out of 201 (136 with available follow-up data) medulloblastoma patients seen or discussed in our institution over the past 10 years.
Conclusions
These lesions can grow over time and pose a differential diagnostic challenge with metastatic disease when identified. The skull and subdural space should be scrutinized for secondary lesions on surveillance imaging of patients with medulloblastoma who have received craniospinal irradiation as knowledge of this benign occurrence will assist with management.
Similar content being viewed by others
Availability of data and material (data transparency)
All relevant data is included.
References
Anscher MS (2005) The irreversibility of radiation-induced fibrosis: fact or folklore? J Clin Oncol 23:8551–8552. https://doi.org/10.1200/JCO.2005.03.6194
Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ (2009) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood cancer survivor study. J Natl Cancer Inst 101:946–958. https://doi.org/10.1093/jnci/djp148
Brandao LA, Young Poussaint T (2017) Posterior fossa tumors. Neuroimaging Clin N Am 27:1–37. https://doi.org/10.1016/j.nic.2016.08.001
Cohen LE, Gordon JH, Popovsky EY, Sainath NN, Feldman HA, Kieran MW, Gordon CM (2012) Bone density in post-pubertal adolescent survivors of childhood brain tumors. Pediatr Blood Cancer 58:959–963. https://doi.org/10.1002/pbc.23300
Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL et al (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572–582. https://doi.org/10.3171/jns.1990.72.4.0572
Frange P, Alapetite C, Gaboriaud G, Bours D, Zucker JM, Zerah M, Brisse H, Chevignard M, Mosseri V, Bouffet E, Doz F (2009) From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000). J Neuro-Oncol 95:271–279. https://doi.org/10.1007/s11060-009-9927-z
Gomez CK, Schiffman SR, Bhatt AA (2018) Radiological review of skull lesions. Insights Imaging 9:857–882. https://doi.org/10.1007/s13244-018-0643-0
Koral K, Roy D, Timmons CF, Gargan L, Bowers DC (2012) Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor. Acad Radiol 19:35–39. https://doi.org/10.1016/j.acra.2011.08.018
Millard NE, De Braganca KC (2016) Medulloblastoma. J Child Neurol 31:1341–1353. https://doi.org/10.1177/0883073815600866
Na JY, Lee MC, Jung S, Kim HS (2012) A mass lesion in the skull after radiotherapy for medulloblastoma. Neuropathology 32:583–585. https://doi.org/10.1111/j.1440-1789.2012.01309.x
Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202–4208. https://doi.org/10.1200/JCO.2006.06.4980
Packer RJ, Sutton LN, D’Angio G, Evans AE, Schut L (1985) Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma. Pediatr Neurosci 12:272–282. https://doi.org/10.1159/000120264
Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D’Angio G, Wechsler-Jentzsch K, Reaman G, Cohen BH, Bruce DA, Rorke LB, Molloy P, Ryan J, LaFond D, Evans AE, Schut L (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698. https://doi.org/10.3171/jns.1994.81.5.0690
Tong L, Zhu G, Wang J, Sun R, He F, Zhai J (2018) Suppressing angiogenesis regulates the irradiation-induced stimulation on osteoclastogenesis in vitro. J Cell Physiol 233:3429–3438. https://doi.org/10.1002/jcp.26196
Ugga L, Cuocolo R, Cocozza S, Ponsiglione A, Stanzione A, Chianca V, D’Amico A, Brunetti A, Imbriaco M (2018) Spectrum of lytic lesions of the skull: a pictorial essay. Insights Imaging 9:845–856. https://doi.org/10.1007/s13244-018-0653-y
Wallace D, Taylor DR, Pan H, Hwang S, Lucas JT Jr, Klimo P Jr, Upadhyaya SA, Boop FA (2020) Treatment-related calvarial lesions in pediatric brain tumor survivors. Pediatr Blood Cancer 67:e28189. https://doi.org/10.1002/pbc.28189
Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ (2016) Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol 17:287–298. https://doi.org/10.1016/S1470-2045(15)00167-9
Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832–845. https://doi.org/10.1200/JCO.1999.17.3.832
Author information
Authors and Affiliations
Contributions
All authors have contributed significantly to the design, data collection, and writing of this manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Ethics approval
Institutional review board approval was obtained for completion of this study.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Code availability
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kaneva, K., Wadhwani, N., DiPatri, A.J. et al. Benign skull and subdural lesions in patients with prior medulloblastoma therapy. Childs Nerv Syst 37, 359–366 (2021). https://doi.org/10.1007/s00381-020-04874-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04874-2